Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.
Next-generation sequencing - Insights
Browse our comprehensive next-generation sequencing test menu for patients who have bleeding and thrombosis disorders.
Minimal residual disease - Insights
Get full-spectrum minimal residual disease testing options, all from one laboratory, with experts to support testing decisions and results.
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
What's New in Health Care Reform: Dec. 19 - Insights
Top highlights include: NIH to spend up to $20 million on search for alternatives to fetal tissue for research, hospital beds get digital upgrade, cocaine deaths increase amid ongoing national opioid crisis, health insurers look to digital...
What's New in Health Care Reform: Dec. 5 - Insights
Top highlights include: Minnesota OKs medical marijuana to treat Alzheimer's, U.S. life expectancy declines again, polio-like disease in U.S. kids appears to have peaked for 2018, methamphetamine use by pregnant women, and the effects of...
Week in Review: July 16 - Insights
Top highlights include: a third dose of COVID-19 vaccine sparking debate over booster shots, rare reactions with the J&J COVID-19 vaccine, and can vaccinated people get long Covid.
Industry Archives - Page 4 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Industry Archives - Page 2 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Industry Archives - Page 3 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...